Published 2022
| Version v1
Publication
Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study
- Creators
- Banna, Giuseppe L
- Cantale, Ornella
- Muthuramalingam, Sethupathi
- Cave, Judith
- Comins, Charles
- Cortellini, Alessio
- Addeo, Alfredo
- Signori, Alessio
- McKenzie, Hayley
- Escriu, Carles
- Barone, Gloria
- Chan, Samuel
- Hicks, Alexander
- Bainbridge, Hannah
- Pinato, David J
- Ottensmeier, Christian
- Gomes, Fabio
Description
Efficacy outcomes and prognostic factors of real-world patients with advanced non-small cell lung cancer (aNSCLC) treated with first-line chemoimmunotherapy are still limited.
Additional details
- URL
- http://hdl.handle.net/11567/1091154
- URN
- urn:oai:iris.unige.it:11567/1091154
- Origin repository
- UNIGE